Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
465.89
-2.69 (-0.57%)
At close: Sep 12, 2025, 4:00 PM EDT
469.99
+4.10 (0.88%)
After-hours: Sep 12, 2025, 7:31 PM EDT
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
28
Consensus Rating
Strong Buy
Price Target
$424.22
Upside
-8.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $280 → $515 | Buy | Maintains | $280 → $515 | +10.55% | Sep 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $450 → $470 | Buy | Maintains | $450 → $470 | +0.88% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $570 | Strong Buy | Reiterates | $570 | +22.35% | Sep 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $527 → $583 | Strong Buy | Maintains | $527 → $583 | +25.14% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $500 → $570 | Strong Buy | Maintains | $500 → $570 | +22.35% | Aug 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $348 → $475 | Buy | Maintains | $348 → $475 | +1.96% | Aug 6, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $490 | Hold → Buy | Upgrades | $490 | +5.18% | Aug 4, 2025 |
| Wolfe Research | Wolfe Research | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Aug 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $342 → $450 | Buy | Maintains | $342 → $450 | -3.41% | Aug 1, 2025 |
| UBS | UBS | Strong Buy Maintains $403 → $550 | Strong Buy | Maintains | $403 → $550 | +18.05% | Aug 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $390 → $415 | Strong Buy | Maintains | $390 → $415 | -10.92% | Aug 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $333 → $395 | Hold | Maintains | $333 → $395 | -15.22% | Aug 1, 2025 |
| Raymond James | Raymond James | Buy Reiterates $370 → $424 | Buy | Reiterates | $370 → $424 | -8.99% | Aug 1, 2025 |
| Barclays | Barclays | Buy Maintains $329 → $460 | Buy | Maintains | $329 → $460 | -1.26% | Aug 1, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $304 → $449 | Buy | Maintains | $304 → $449 | -3.63% | Aug 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $325 → $400 | Strong Buy | Maintains | $325 → $400 | -14.14% | Aug 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.